Hong Kong
· Delayed Price · Currency is HKD Broncus Holding Company Description
Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, and internationally.
The company offers InterVapor, a thermal vapor treatment system to treat chronic obstructive pulmonary disease (COPD); BroncAblate Radiofrequency Ablation System (BRONC-RFⅡ), a transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation (TLD) Ablation System for the treatment of COPD; H-Marker, treatment for lung cancer/lung nodules; Mist Fountain, a disposable nebulizing micro-catheter for endoscope used for airway anaesthesia, precise antibacterial and anti-inflammatory, tuberculosis drug delivery, phlegm reduction and elimination, thoracic surgery staining location, etc.; and BroncTru, a disposable transbronchoscopic puncture dilatation catheter.
It also provides navigation products, such as LungPoint Virtual Bronchoscopic Navigation, a computer-assisted image-based navigation software system; LungPoint Plus/Archimedes Lite, a system that provides real-time navigation within the airways for lung biopsy and other procedures; and LungPoint ATV System, an archimedes system.
In addition, the company offers diagnosis products, such as FleXNeedle, a multipurpose biopsy needle; Archimedes Sheath, a sterile single-use flexible tube that provides a working channel during a bronchoscopic procedure; Archimedes Dilation Balloon, a sterile single-use flexible tube with a balloon at or near the distal tip that is inserted through the bronchoscope or sheath and used to dilate the target lung tissue of the bronchial tree; Steerable Sheath; and BioStarNeedle, as well as Endoluminal Robotic System.
The company was incorporated in 2012 and is headquartered in Hangzhou, China.
| Country | Cayman Islands |
| Founded | 2012 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 200 |
| CEO | Hong Xu |
Contact Details
Address: Building 8 Hangzhou China | |
| Phone | 86 571 8659 5016 |
| Website | broncus.com |
Stock Details
| Ticker Symbol | 2216 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | KYG1609T1022 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Hong Xu | Chairman of the Board and Chief Executive Officer |
| Elaine Lu | Director of Finance and Administration |
| Thomas M. Keast | Vice President, Operation Director and Scientist in resident |
| Feng Yao | Senior Accountant |
| Ka Yan Suen | Company Secretary |